A Ph.D. in Epidemiology is a graduate degree in the field of hepatitis. This discipline deals with preventing and treating the disease. The field of hepatitis involves many genetically unrelated viruses. The most common of these are hepatitis A and B, which are spread through blood and sexual fluids. While these viruses are curable, they are still an important contributor to global and U.S. disease burdens.
The Centers for Disease Control and Prevention (CDC) maintains surveillance for chronic and acute hepatitis infections. However, data on chronic infection is limited due to a lack of reporting from states. In 2014, the CDC received reports on hepatitis B and C virus infections from 40 states, which likely underestimate the true incidence of these diseases.
The Centers for Disease Control and Prevention (CDC) carry out national surveillance for acute and chronic infections. Because state reporting is incomplete, these data are not comprehensive. In 2014, CDC received reports from 40 states on acute hepatitis B and 37 states on chronic hepatitis C infection. The CDC reports are not likely to represent the actual incidence of these diseases.
Candidates who want to take admission in Ph.D. must have a post-graduate degree in Epidemiology of Viral Hepatitis and Liver Diseases and its relevant discipline with at least 55% marks from a recognized university and must have passed the national level entrance examination or university level entrance examination. National level entrance exams like UGC NET / UGC CSIR NET / GATE / SLET or University entrance exams consist of written tests and personal interviews.
A Ph.D. in Epidemiology focuses on the prevention and control of viral hepatitis. The disease is caused by a virus that affects the liver. The three most common types of viral hepatitis are hepatitis B, hepatitis C, and hepatitis D. Infection with any of these viruses can lead to chronic hepatitis, liver cancer, and other health problems.
The high mortality rates associated with CHC underscore the importance of better screening and treatment. Today, most people with the disease have an effective oral antiviral therapy that leads to a sustained viral response. However, according to Holmberg et al., only one-third of people who have been diagnosed with HCV seek treatment, and only five to seven percent of those who have been successfully treated receive the right kind of treatment.
Increasing public awareness about this disease is a primary objective of Epidemiology of Viral Hepatitis. The disease has a long-term history and can lead to cancer or liver disease. This field requires highly qualified researchers and medical experts to combat its prevalence. The goal of the program is to develop a more complete understanding of this deadly disease and its management.
After earning a Ph.D. in Epidemiology, you can go on to a variety of positions. Most of these positions focus on disease surveillance and control. The Division of Viral Hepatitis conducts collaborative research with domestic and international partners. These projects range from health surveillance to cost-effectiveness studies and behavioral research. Your research may also help prevent the spread of viral hepatitis, blood-borne infections, and sexual diseases.
You will study the causes and control of liver infections, including hepatitis B and C. The HBV virus is the main cause of hepatitis B and C. Patients with hepatitis B virus have a high risk of developing cirrhosis and liver cancer. People with hepatitis B are at an increased risk of contracting the disease due to prolonged contact with an infected family member.
Ultimately, you will have the opportunity to apply the findings of your studies to the treatment of hepatitis and liver diseases. In the field of prevention, you will work on preventing and controlling the development of the disease. For example, you will study the causes of hepatitis B and C. If you want to be able to prevent the spread of the disease, you should educate yourself about the risks.
The future scope of this degree lies in the field of health care. Its main focus is the epidemiology of viral hepatitis and li. There are several avenues for this doctoral degree. One of these is the epidemiology of infectious diseases. The study of infectious diseases and their transmission is essential for public health.
A Ph.D. in the epidemiology of viral hepatitis and li disease can open new opportunities for the doctoral student. For example, there are currently few studies on the global burden of the disease caused by viral hepatitis. In addition to the prevention of HIV, there are many research gaps related to the disease.
The field of public health can be very broad. For example, it covers the analysis of hepatitis B and C infection. In the United States, the CDC has compiled interagency guidelines for screening organ donors. This research has implications for international human health. The CDC is also working on an HIV/AIDS study.
The future scope of a Ph.D. in Epidemiology of Hepatitis and Li, For instance, can study the epidemiology of chronic hepatitis and cancer. It may also investigate the prevention of chronic hepatitis. In this field, a doctor can also work in HIV services.
The Ph.D. in Epidemiology of Viral Hepatitis and Liver Diseases course is a minimum of 3 years and a maximum of 5 duration. This depends on the university offering the course.
The average fee for an Epidemiology of Viral Hepatitis and Liver Diseases degree is between INR 50000 and INR 500000.
Chennai
Chettinad Academy of Research and Education
.
5 Years
PhD
Established in | 2008 |
University Type | Deemed University |
Recognized by | UGC , ASCI , MCI , |
Courses | 9 |
Get Latest Notification of Colleges, Exams and News.